Page last updated: 2024-08-26

1,3,4-oxadiazole and isoniazid

1,3,4-oxadiazole has been researched along with isoniazid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Huszár, S; Janoušek, J; Korduláková, J; Krátký, M; Madacki, J; Mikušová, K; Stolaříková, J; Švarcová, M; Trejtnar, F; Vinšová, J; Vosátka, R1
Bleotu, C; Diaconu, CC; Hanganu, A; Ionita, P; Limban, C; Matei, L; Nemeș, RM; Nicolau, I; Nuta, DC; Păun, A; Radulescu, C; Tatibouët, A; Zarafu, I1
Abd Ghani, MS; Awang, K; Azmi, MN; Hasmaruddin, NS; Hassan, MZ; Mat Ali, NA; Mohamad, S; Osman, H; Parumasivam, T1

Other Studies

3 other study(ies) available for 1,3,4-oxadiazole and isoniazid

ArticleYear
New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    European journal of medicinal chemistry, 2018, May-10, Volume: 151

    Topics: Antitubercular Agents; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; Tuberculosis

2018
Synthesis, Characterization, and Biologic Activity of New Acyl Hydrazides and 1,3,4-Oxadiazole Derivatives.
    Molecules (Basel, Switzerland), 2020, Jul-21, Volume: 25, Issue:14

    Topics: Anti-Infective Agents; Antineoplastic Agents; Antitubercular Agents; Arylamine N-Acetyltransferase; Benzoates; Carboxylic Acids; Drug Evaluation, Preclinical; G1 Phase; Gene Expression Regulation; Humans; Hydrazines; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles; RNA, Messenger

2020
Synthesis, characterization, anti-mycobacterial activity and in silico study of new 2,5-disubstituted-1,3,4-oxadiazole derivatives.
    Tropical biomedicine, 2022, Sep-01, Volume: 39, Issue:3

    Topics: Antitubercular Agents; Isoniazid; Ligands; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Oxadiazoles

2022